This report showed that manipulation of PPAR-γ activity can modulate M1/M2 macrophage polarization, having the potential to prevent development of nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.